Virbac Stock Falls Below Its Three Moving Averages Mid-Session
The veterinary laboratory in Carros declines midday in a downward trending Paris market. The stock erases part of its rebound from the end of last week and falls below key technical levels. The overall context remains weighed down by the rise in Brent and the strength of the dollar.
Virbac Stock Drops 1.71% in Session Amid Broader Market Decline
Virbac stock loses 1.71% to €344.00 during the session, while the SBF 120 is down 0.45% and the CAC 40 drops 0.48%. The stock ranks beyond the hundredth position in the broad index, not featuring among the extreme movements of the day. The decline erases the rebound that began last Friday, documented at the end of last week. Over a month, the loss is 7%, while the annual gain remains at 5.7%. The market context continues to be heavy. Brent has risen above $95 following new strikes in Lebanon, and the dollar is at a two-month high after a strong U.S. employment report. These two factors do not directly affect the veterinary laboratory but add to the general gloom over European stocks.
Crossing Below Three Moving Averages, Approaching the €339 Support
The price falls below its three moving averages: the MM20 at €353.00 (a gap of -2.55%), the MM50 at €359.74 (-4.38%), and the MM200 at €348.83 (-1.38%). This configuration indicates a loss of momentum in the short and medium term. The RSI at 45 remains in the neutral zone, with no sign of seller exhaustion. The identified support at €339.00 is now about 1.5% below the current price, and will be the next level to watch if the slide continues. The upper resistance remains at €378.50, a level approached in May after TP Icap raised its target to €412 in mid-May. The underlying trend remains one of consolidation, with the stock now operating in the lower half of its recent channel.
